Clinical trial
Optimizing Multimodal Pain Regimens: Evaluating the Analgesic Effect of Pill Quantity and Gabapentin in Reducing Opioid Dependency
NCT07750639 is registered in ClinicalTrials.gov with AdventHealth as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimizing Multimodal Pain Regimens: Evaluating the Analgesic Effect of Pill Quantity and Gabapentin in Reducing Opioid Dependency
- Lead sponsor
- AdventHealth
- Phase
- Phase 4
- Overall status
- Enrolling by invitation
- Start date
- August 1, 2024
- Completion date
- December 30, 2027
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
opioid abuse (disorder), opioid analgesia, opioid analgesic adverse reaction, opioid consumption